People · Operator
Named in public records as an officer, director or promoter · active 2009–2017 · Other Health Care, Healthtech, Pharma, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Intrapace Inc | — | Other Health Care | Series D+ | $179.1M | $76.8M | 2010 |
| Direct Flow Medical, Inc. | — | Other Health Care | Series C | $170.5M | $619.6M | 2009 |
| Conventus Orthopaedics Inc | — | Other Health Care | Series C | $144.2M | $921.2M | 2009 |
| Tryton Medical Inc | — | Healthtech | Series B | $46.2M | $99.1M | 2010 |
| Solace Therapeutics Inc | — | Pharma | Series A | $28.4M | $202.2M | 2012 |
| Interlace Medical Inc | — | Other Health Care | Series B | $20.5M | $454.2M | 2009 |
| Pathway Medical Technologies Inc | — | Biotechnology | Series A | $9.9M | $359.1M | 2010 |
J. Daniel Cole at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside J. Daniel Cole on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paul Buckman | 2 | 10 |
| Kevin G Connors | 2 | 3 |
| William H. Gruber | 2 | 2 |
| Brian R. Smith | 1 | 21 |
| PAUL LAVIOLETTE | 1 | 12 |
| Steven Hochberg | 1 | 9 |
| Jeani Delagardelle | 1 | 8 |
| Michael DeVries | 1 | 8 |
| Andrew ElBardissi | 1 | 7 |
| TING PAU OEI | 1 | 7 |
| Eric Bell | 1 | 7 |
| Martin Dieck | 1 | 7 |
| Mir Imran | 1 | 6 |
| Robert A Kukuljan | 1 | 6 |
| Lee Wrubel | 1 | 5 |
| CHARLES CHON | 1 | 5 |
| D. Keith Grossman | 1 | 5 |
| David Auth | 1 | 5 |
| David Blue | 1 | 5 |
| Mark Weeks | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.